BLUE SKY URANIUM CORP (BSK.CA) Fundamental Analysis & Valuation

TSX-V:BSK • CA0960495079

Current stock price

0.06 CAD
0 (0%)
Last:

This BSK.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. BSK.CA Profitability Analysis

1.1 Basic Checks

  • In the past year BSK has reported negative net income.
  • In the past year BSK has reported a negative cash flow from operations.
  • BSK had negative earnings in each of the past 5 years.
  • BSK had a negative operating cash flow in each of the past 5 years.
BSK.CA Yearly Net Income VS EBIT VS OCF VS FCFBSK.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -575.49%, BSK is doing worse than 88.35% of the companies in the same industry.
Industry RankSector Rank
ROA -575.49%
ROE N/A
ROIC N/A
ROA(3y)-373.44%
ROA(5y)-290.37%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BSK.CA Yearly ROA, ROE, ROICBSK.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K

1.3 Margins

  • BSK does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BSK.CA Yearly Profit, Operating, Gross MarginsBSK.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. BSK.CA Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for BSK has been increased compared to 1 year ago.
  • BSK has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, BSK has a worse debt to assets ratio.
BSK.CA Yearly Shares OutstandingBSK.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
BSK.CA Yearly Total Debt VS Total AssetsBSK.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M

2.2 Solvency

  • Based on the Altman-Z score of -86.59, we must say that BSK is in the distress zone and has some risk of bankruptcy.
  • BSK's Altman-Z score of -86.59 is on the low side compared to the rest of the industry. BSK is outperformed by 85.44% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -86.59
ROIC/WACCN/A
WACCN/A
BSK.CA Yearly LT Debt VS Equity VS FCFBSK.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M -4M

2.3 Liquidity

  • BSK has a Current Ratio of 0.21. This is a bad value and indicates that BSK is not financially healthy enough and could expect problems in meeting its short term obligations.
  • BSK's Current ratio of 0.21 is on the low side compared to the rest of the industry. BSK is outperformed by 81.07% of its industry peers.
  • A Quick Ratio of 0.21 indicates that BSK may have some problems paying its short term obligations.
  • BSK has a Quick ratio of 0.21. This is amonst the worse of the industry: BSK underperforms 81.07% of its industry peers.
Industry RankSector Rank
Current Ratio 0.21
Quick Ratio 0.21
BSK.CA Yearly Current Assets VS Current LiabilitesBSK.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. BSK.CA Growth Analysis

3.1 Past

  • BSK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -224.59%.
EPS 1Y (TTM)-224.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocksShow best growing peers

0

4. BSK.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • BSK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BSK.CA Price Earnings VS Forward Price EarningsBSK.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BSK.CA Per share dataBSK.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -0 -0.01 -0.01

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BSK.CA Dividend Analysis

5.1 Amount

  • No dividends for BSK!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BSK.CA Fundamentals: All Metrics, Ratios and Statistics

BLUE SKY URANIUM CORP

TSX-V:BSK (4/20/2026, 7:00:00 PM)

0.06

0 (0%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)11-27
Earnings (Next)04-21
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners2.97%
Ins Owner ChangeN/A
Market Cap26.05M
Revenue(TTM)N/A
Net Income(TTM)-6.54M
Analysts84.44
Price Target0.12 (100%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-20%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -575.49%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-373.44%
ROA(5y)-290.37%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.21
Quick Ratio 0.21
Altman-Z -86.59
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-224.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-73.91%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-66.11%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-57.65%
OCF growth 3YN/A
OCF growth 5YN/A

BLUE SKY URANIUM CORP / BSK.CA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of BLUE SKY URANIUM CORP (BSK.CA) stock?

ChartMill assigns a fundamental rating of 0 / 10 to BSK.CA.


Can you provide the valuation status for BLUE SKY URANIUM CORP?

ChartMill assigns a valuation rating of 0 / 10 to BLUE SKY URANIUM CORP (BSK.CA). This can be considered as Overvalued.


Can you provide the profitability details for BLUE SKY URANIUM CORP?

BLUE SKY URANIUM CORP (BSK.CA) has a profitability rating of 0 / 10.


Can you provide the financial health for BSK stock?

The financial health rating of BLUE SKY URANIUM CORP (BSK.CA) is 0 / 10.